ACUC — AcuCort AB Share News
0.000.00%
- SEK135.04m
- SEK113.89m
- SEK0.69m
Brief: AcuCort Reports Positive Outcome Of The Expert Group Work
Brief: AcuCort Appoints Interim CEO
Brief: AcuCort Q3 Net Loss Widens To SEK 2.6 Mln
Brief: AcuCort: ISICORT Does Not Meet Bioequivalence Requirements For US Registration
Brief: AcuCort Rights Issue Subscribed To 102%
Brief: AcuCort Carries Out Rights Issue Of About SEK 41.2 Mln
Brief: AcuCort April-June Loss After Tax Widens To SEK 2.2 Million
Brief: AcuCort Expects To Have Patent Application In EU Approved
Brief: AcuCort Adjusts Accounting Of Intangible Assets
Brief: AcuCort AB Q1 Pre-Tax Loss Narrows To SEK 1.4 Million
Brief: Acucort Reports Positive Results From First Of Two Bioequivalence Studies For US
Brief: AcuCort Q4 Pretax Result Swings To Profit Of SEK 3.2 Million
Brief: Acucort Gets Approval To Start Bioequivalence Study For The US
Brief: Acucort Presents Positive Results From Bioequivalence Study
Brief: Acucort Gets Positive Response From FDA
Brief: Acucort Obtains Regulatory Approval To Start Bioequivalence Study For The EU
Brief: AcuCort Carries Out New Share Issue of SEK 9.4 Million
Brief: Acucort Q2 Pre-Tax Loss Widens To SEK 4.7 Million
Brief: AcuCort Signs Agreement With CRO Quinta-Analytica